MedTrace Logo

Is There a Transient Rebound Effect of Platelet Reactivity Following Cessation of Dual Antiplatelet Therapy With Ticagrelor - a Single Center Prospective Observational Trial

NCT02808039 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-06-21

No results posted yet for this study

Summary

to assess whether cessation of 12 months DAPT regimen containing Ticagrelor results in a hyperreactive phase of platelet function

Conditions

  • Dual Antiplatelet Therapy
  • Platelet Reactivity

Interventions

OTHER

Platelet reactivity testing

assessment of platelet aggregation using the VerifyNow purinergic receptor P2Y, G-protein coupled, 12 (P2Y12) platelet function assay (Accumetrics, San Diego, California)

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • Guy Witberg, MD · Rabin Medical Center, Department of Cardiology

  • Eli Lev, MD · Rabin Medical Center, Department of Cardiology

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02808039 on ClinicalTrials.gov